Influenza A virus induces an immediate cytotoxic activity in all major subsets of peripheral blood mononuclear cells

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Sturlan, Sanda ^a   Sachet, Monika ^a   Baumann, Suzann ^a   Kuznetsova, Irina ^a   Spittler, Andreas ^a   Bergmann, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; INFLUENZA VACCINE; INTERFERON; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL STRAIN CACO 2; CELL STRAIN MCF 7; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLUENZA; INFLUENZA VIRUS A; INNATE IMMUNITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; VIRUS ATTACHMENT; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYTOKINES; CYTOTOXINS; FEMALE; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; SPLEEN; VIRUS REPLICATION;

INFLUENZA A VIRUS;

EID: 76549097491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004122     Document Type: Article

References (33)

1. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517-523.
2. Chaperot L, Blum A, Manches O, Lui G, Angel J, et al. (2006) Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol 176: 248-255.
3. Hicks AM, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, et al. (2006) Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A 103: 7753-7758.
4. Hicks AM, Willingham MC, Du W, Pang CS, Old LJ, et al. (2006) Effector mechanisms of the anti-cancer immune responses of macrophages in SR/CR mice. Cancer Immun 6: 11.
5. Stary G, Bangert C, Tauber M, Strohal R, Kopp T, et al. (2007) Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J Exp Med 204: 1441-1451.
6. Ullrich E, Menard C, Flament C, Terme M, Mignot G, et al. (2008) Dendritic cells and innate defense against tumor cells. Cytokine Growth Factor Rev 19: 79-92.
7. Woo Y, Adusumilli PS, Fong Y (2006) Advances in oncolytic viral therapy. Curr Opin Investig Drugs 7: 549-559.
8. Stanford MM, Breitbach CJ, Bell JC, McFadden G (2008) Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes? Curr Opin Mol Ther 10: 32-37.
9. Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, et al. (2000) Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74: 6203-6206.
10. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, et al. (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252: 324-330.
11. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
12. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, et al. (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101: 5598-5603.
13. Wang X, Li M, Zheng H, Muster T, Palese P, et al. (2000) Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74: 11566-11573.
14. Stasakova J, Ferko B, Kittel C, Sereinig S, Romanova J, et al. (2005) Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol 86: 185-195.
15. Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, et al. (2006) Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 80: 6295-6304.
16. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-Imediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001.
17. Talon J, Salvatore M, O'Neill RE, Nakaya Y, Zheng H, et al. (2000) Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci U S A 97: 4309-4314.
18. Efferson CL, Tsuda N, Kawano K, Nistal-Villan E, Sellappan S, et al. (2006) Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells. J Virol 80: 383-394.
19. Washburn B, Weigand MA, Grosse-Wilde A, Janke M, Stahl H, et al. (2003) TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus. J Immunol 170: 1814-1821.
20. Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, et al. (2003) Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 171: 2366-2373.
21. Urosevic M, Fujii K, Calmels B, Laine E, Kobert N, et al. (2007) Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas. J Clin Invest 117: 2834-2846.
22. Chawla-Sarkar M, Leaman DW, Jacobs BS, Borden EC (2002) IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis. J Immunol 169: 847-855.
23. Rothenfusser S, Hornung V, Krug A, Towarowski A, Krieg AM, et al. (2001) Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Eur J Immunol 31: 3525-3534.
24. Trinchieri G (1989) Biology of natural killer cells. Adv Immunol 47: 187-376.
25. Lanier LL (2008) Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8: 259-268.
26. Kemp TJ, Moore JM, Griffith TS (2004) Human B cells express functional TRAIL/Apo-2 ligand after CpG-containing oligodeoxynucleotide stimulation. J Immunol 173: 892-899.
27. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, et al. (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 1: 475-482.
28. Mozdzanowska K, Maiese K, Gerhard W (2000) Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance. J Immunol 164: 2635-2643.
29. Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, et al. (2007) NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol 178: 2688-2698.
30. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
31. He XS, Draghi M, Mahmood K, Holmes TH, Kemble GW, et al. (2004) T celldependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest 114: 1812-1819.
32. Oh S, Eichelberger MC (2000) Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells. J Virol 74: 7738-7744.
33. Egorov A, Brandt S, Sereinig S, Romanova J, Ferko B, et al. (1998) Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol 72: 6437-6441.